Search results
Nov 20, 2023 · William Ho is a biotech entrepreneur and investor who co-founded IN8bio, a company developing gamma-delta T-Cells as cellular therapies for cancer. He explains how gamma-delta T-Cells can kill tumor cells without causing toxicity and how they can be used for both solid and liquid tumors.
- Mike Hollan
William Ho is a company Co-Founder, and has served as the President, Chief Executive Officer and Director of IN8bio since its inception. Mr. Ho has worked in the biotechnology industry for almost 20 years.
- Director, President, CEO & Co-Founder
- In8bio, In8bio
MS Amlin Asia Pacific. Accessible, approachable and relevant. We provide reinsurance and speciality insurance via MS Amlin Asia Pacific, part of Lloyd’s Asia, for the admitted market under the Lloyd’s licence.
MS Amlin has appointed William Ho (pictured) as CEO of the company’s Asia-Pacific operations, subject to regulatory approval. He will succeed Simon Clarke, who is stepping down after 10 years ...
Feb 4, 2020 · Insurer and reinsurer MS Amlin has revealed that William Ho, currently Head of Reinsurance (Asia), has been appointed Chief Executive Officer (CEO) of MS Amlin Asia Pacific.
InsuranceAsia News (IAN) recently caught up with William Ho, MS Amlin’s Asia Pacific chief executive. Singapore-based Ho discussed the firm’s latest insurance linked securities (ILS) transaction in the region and the future of Asia as an ILS hub.
William Ho is the Co-Founder, President, CEO and Director of IN8bio, a biotechnology company. He has over 20 years of experience in the industry, working as an investor, analyst and executive at various firms.
